Outlook Therapeutics shares are trading lower. The company announced a $10 million bought deal offering of common stock which was afterwards increased to $50 million.

by | Nov 24, 2021 | Extra Jobs | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.